Heron Therapeutics reports Q2 EPS (6c), consensus (4c)
PremiumThe FlyHeron Therapeutics reports Q2 EPS (6c), consensus (4c)
3M ago
Is HRTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is HRTX a Buy, Before Earnings?
3M ago
Heron Therapeutics management to meet virtually with Needham
Premium
The Fly
Heron Therapeutics management to meet virtually with Needham
4M ago
Heron Therapeutics announces acceptance of PAS application for ZYNRELE
PremiumThe FlyHeron Therapeutics announces acceptance of PAS application for ZYNRELE
4M ago
Heron Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Heron Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
Heron Therapeutics Submits ZYNRELEF® Supplement to FDA
Premium
Company Announcements
Heron Therapeutics Submits ZYNRELEF® Supplement to FDA
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
Heron Therapeutics management to meet virtually with Northland
Premium
The Fly
Heron Therapeutics management to meet virtually with Northland
7M ago
Heron Therapeutics initiated with an Overweight at Capital One
Premium
The Fly
Heron Therapeutics initiated with an Overweight at Capital One
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100